Brez internetne povezave — prikazana je shranjena različica strani.

武田薬品工業

Takeda Pharmaceutical Co Ltd ADRUSUSD
← Na Filter Delnic

Takeda Pharmaceutical Co Ltd ADR (US:TKPHF) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 3. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O Podjetju

Spletna Stran
takeda.co.jp
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
TOKYO, Japan
Izvršni Direktor
Julie Kim
Zaposleni
47 029
Ustanovljena
1781
Delnice v Obtoku
1.6 mrd. na dan 2026-10-15
DatumDelniceSprememba
15.10.20261.6 mrd.—brez bistvenih sprememb
14.10.20261.6 mrd.—brez bistvenih sprememb
13.10.20261.6 mrd.—brez bistvenih sprememb
09.10.20261.6 mrd.—brez bistvenih sprememb
08.10.20261.6 mrd.—brez bistvenih sprememb
07.10.20261.6 mrd.
Število delnic po poročilih podjetja. Razcep se prepozna po skoku števila za celo število krat.
Prosto Prenosljive Delnice
3.16 mrd.
Tržna Kapitalizacija
9.88 bil. JPY
Notranje Osebe
0.07%
Institucionalni Vlagatelji
3.31%
Panoga (SIC)
Pharmaceutical Preparations
Pravna Oblika
T417
ISIN
US8740602052
LEI
549300ZLMVP4X0OGR454
Delež Izplačila
izguba
FCF
627 mrd. JPY
Izplačilo / FCF
49%
Dolg
4.94 bil. JPY
7.1 let FCF
Dividendni Staž
—
Dobički, FCF in izplačane dividende — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
Opis

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands. It has licensing and collaboration for the development and commercialization of products with Arrowhead Pharmaceuticals, Cour Pharmaceuticals, Engitix, Halozyme, Mirum Pharmaceuticals, Ucsd/Fortis Advisors, Zedira/Dr. Falk Pharma, Ac Immune, Acurastem, Anima Biotech, Biomarin, Denali Therapeutics, Luxna Biotech, Neurocrine Biosciences, Peptidream, Abbvie, Adimab, Ascentage Pharma, Crescendo Biologics, Exelixis, F-Star, Gsk, Heidelberg Pharma, Innovent Biologics, Keros Therapeutics, Kumquat Biosciences, Protagonist Therapeutics, Halozyme, Kamada, Johnson & Johnson/Momenta Pharmaceuticals, Previpharma, Novavax, Bridgene Biosciences, Charles River Laboratories, Iambic Therapeutics, Ipsen, Km Biologics, Massachusetts Institute Of Technology, and Nabla Bio. The company operates in Japan, the United States. Europe, Canada, Latin America, China, Asia, Russia/Commonwealth of Independent States, the Middle East, Oceania, and Africa. The company was founded in 1781 and is headquartered in Chuo, Japan.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
US USA StocksTKPHF OTCUSD33.85 -5.31%navadne delnice
TSE Tokyo Stock Exchange4502 glavnaJPY6 183 +4.99%navadne delnice
VI Vienna Stock ExchangeTKD dodatnaEUR33.01 +1.29%navadne delnice

Cena v 3 Mesecih

dan rasti dan padca ex-dividendni datum datum izplačilaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Dividende

Na leto, US:TKPHF: 202 JPY (2 izpl.)

Takeda Pharmaceutical Co Ltd ADR (TKPHF) izplačuje dividende dvakrat letno. Na leto (12 mesecev do in vključno z najnovejšim napovedanim plačilom): 202 JPY na delnico (plačila: 2). Glede na zgodovino izplačil se naslednji datum ex-dividende pričakuje okoli 31.03.2027.

Ex-DatumIzplačiloZnesek%VrstaOznaka
2026-09-30—102.0000 JPY1.7/3.4 %polletnoUS:TKPHF
2026-03-312026-06-25100.0000 JPY1.8/3.7 %polletnoUS:TKPHF
2025-09-302025-12-01100.0000 JPY2.2/4.3 %polletnoUS:TKPHF
2025-03-312025-06-2698.0000 JPY2.0/3.9 %polletnoUS:TKPHF
2024-09-302024-12-0298.0000 JPY2.4/≈4.7 %polletnoUS:TKPHF
2024-03-282024-06-2794.0000 JPY2.1/≈4.3 %polletnoUS:TKPHF

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
Capital Research Global…0.6%19.3 mio.2026-06-30
AMERICAN MUTUAL FUND0.57%18.16 mio.2026-06-30
FMR, LLC0.3%9.6 mio.2026-06-30
Morgan Stanley0.22%6.99 mio.2026-06-30
Adage Capital Partners G…0.19%6.05 mio.2026-06-30
Goldman Sachs Group Inc0.16%5.13 mio.2026-06-30
Brandes Investment Partn…0.14%4.54 mio.2026-06-30
Arrowstreet Capital, Lim…0.12%3.73 mio.2026-06-30
Blackrock Inc.0.12%3.69 mio.2026-06-30
Renaissance Technologies…0.08%2.57 mio.2026-06-30
Qube Research & Technolo…0.07%2.21 mio.2026-06-30
First TRT Exch-Trd Fd.-F…0.06%1.88 mio.2026-08-31
VanEck ETF Trust-VanEck…0.06%1.79 mio.2026-08-31
Steward Funds Inc-Stewar…0.02%711 8712026-04-30
Mercer Funds-Mercer Non-…0.02%586 0982026-06-30
American Century ETF Tru…0.02%553 0082026-08-31
GOLDMAN SACHS TRUST-Gold…0.02%494 4422026-07-31
WEBER CHRISTOPHE PIERRE…≈0.01%418 8032026-04-27
KIM JULIE SO-YOUNG (Chie…≈0.01%391 4892026-08-10
Trust for Professional M…0.01%170 1132026-05-31
MUTUAL FUND SERIES TRUST…0.01%169 0002026-06-30
PLATFORD GILES RICHARD (…≈0.01%315 8382026-08-10
BITETTI TERESA MARIE (Of…≈0.01%252 0102026-08-10
FURNEY NATALIE ANNE MARI…≈0.01%204 2982026-08-10
DUPREY LAUREN RUSCKOWSKI…≈0.01%191 5222026-09-14
PACHECO RHONDA JANICE (O…≈0.01%182 5072026-08-10
PIGNAGNOLI AGOSTI MARCEL…≈0.01%176 9772026-08-10
RICCI GABRIELE (Chief Te…≈0.01%171 6542026-08-10
Carillon Series Trust-Ca…0%160 0002026-06-30
PLUMP ANDREW STEWART (Of…——2026-09-02